Whole-genome sequencing data — which include information about mitochondrial DNA — offer clues to why mutations in the same gene can lead to autism or cancer.
Cleveland Clinic has been designated a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The new Cleveland Clinic Center for Rare Diseases is one of 40 U.S. academic medical centers selected to join the first-of-it-kind national network dedicated to diagnosing, treating and researching all rare diseases.
The designation from the National Organization for Rare Disorders makes the Clinic one of 40 academic medical centers in the country selected for a network focused on the diagnosis, treatment and research of rare diseases.
The largest cohort of its kind reveals notable genomic features among young premenopausal women with HR-positive early breast cancer and could represent key targets for therapy.